PAR
PAR · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for PAR quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Certificate under SEBI (Depositories and Participants) Regulations, 2018
07 Jul 2026
Trading Window
25 Jun 2026
Action(s) taken or orders passed
10 Jun 2026
Action(s) initiated or orders passed
21 May 2026
Copy of Newspaper Publication
15 May 2026
Outcome of Board Meeting
15 May 2026
Updates
15 May 2026
Updates
15 May 2026
Outcome of Board Meeting
14 May 2026
Outcome of Board Meeting
14 May 2026
Disclosure under SEBI Takeover Regulations
08 Apr 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
07 Apr 2026
Trading Window
26 Mar 2026
Action(s) taken or orders passed
26 Mar 2026
Copy of Newspaper Publication
11 Feb 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Extra Ordinary General Meeting
Extra Ordinary General Meeting
Ex-date: 23 Dec 2024
Annual General Meeting
Annual General Meeting
Ex-date: 13 Sep 2024
Annual General Meeting
Annual General Meeting
Ex-date: 08 Sep 2023
Annual General Meeting
Annual General Meeting
Ex-date: 01 Sep 2022
Interim Dividend - Rs 1.25 Per Share
Interim Dividend - Rs 1.25 Per Share
Ex-date: 22 Nov 2021
Board Meetings
14 May 2026
PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Other business.
14 May 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
14 May 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
10 Feb 2026
PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business.
10 Feb 2026
To consider and approve the financial results for the period ended December 31, 2025 and other business matters
13 Nov 2025
PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2025 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2025 and Other business.
13 Nov 2025
To consider and approve the financial results for the period ended September 30, 2025 and other business matters
29 Aug 2025
PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-Aug-2025 to consider Other business.